Li Yan-Zhu, Zhou Fu-Rong, Chen Xiao-Juan, Liu Yong-Gan
Department of Anorectal, The People's Hospital of Zhongshan, Zhongshan, Guangdong, China.
Front Med (Lausanne). 2024 Dec 17;11:1496086. doi: 10.3389/fmed.2024.1496086. eCollection 2024.
Perianal abscesses pose a considerable obstacle in the realm of postoperative wound treatment owing to their elevated susceptibility to infection and associated consequences. Polymyxin B Ointment, a compound renowned for its antibacterial qualities, has the potential to provide therapeutic advantages by promoting wound healing and mitigating postoperative problems.
Our institution conducted a thorough retrospective analysis spanning from December 2020 to December 2023 to assess the effectiveness of Compound Polymyxin B Ointment in the management of surgical wounds in patients diagnosed with perianal abscesses. The research encompassed a cohort of 100 individuals, who were classified into two groups: a control group that received conventional postoperative care, and an observation group that received supplementary treatment with Compound Polymyxin B Ointment. The evaluation of clinical outcomes involved measuring wound healing effectiveness, pain intensity using the Visual Analogue Scale (VAS), tissue swelling, exudation, necrotic tissue shedding time, duration of hospital stays, and rate of reduction in wound area.
The group that received Compound Polymyxin B Ointment had significant enhancements in wound healing, as seen by a noteworthy 46% of participants completing complete healing, in contrast to the control group's 32%. The VAS was used to quantify pain levels, and the observation group reported a substantial reduction of almost 50% in ratings. Furthermore, this cohort exhibited a 45% decrease in edema and a 50% decline in exudation rates, in addition to a 50% acceleration in the shedding of necrotic tissue. The duration of the hospital stay was reduced by 40%, and the reduction in wound area was 18% higher, suggesting a more effective healing process. In addition, it is worth noting that the observation group had a lower incidence of problems, so underscoring the effectiveness of the ointment in facilitating wound healing and mitigating postoperative difficulties.
The utilization of Compound Polymyxin B Ointment as an adjuvant measure in the surgical treatment of perianal abscesses has been found to have a substantial positive impact on wound healing, pain relief, and complication reduction. This finding provides evidence for the possibility of the ointment as a helpful inclusion in post-surgical wound care procedures among this specific group of patients.
肛周脓肿由于其较高的感染易感性及相关后果,在术后伤口治疗领域构成了相当大的障碍。多粘菌素B软膏是一种以抗菌特性闻名的化合物,它有可能通过促进伤口愈合和减轻术后问题而提供治疗优势。
我们机构进行了一项从2020年12月至2023年12月的全面回顾性分析,以评估复方多粘菌素B软膏在诊断为肛周脓肿患者手术伤口管理中的有效性。该研究涵盖了100名个体,他们被分为两组:一组为接受常规术后护理的对照组,另一组为接受复方多粘菌素B软膏辅助治疗的观察组。临床结果评估包括测量伤口愈合效果、使用视觉模拟量表(VAS)评估疼痛强度、组织肿胀、渗出、坏死组织脱落时间、住院时间以及伤口面积缩小率。
接受复方多粘菌素B软膏治疗的组在伤口愈合方面有显著改善,值得注意的是,46%的参与者实现了完全愈合,而对照组为32%。使用VAS量化疼痛程度,观察组报告评分大幅降低近50%。此外,该组水肿减少45%,渗出率下降50%,坏死组织脱落加速50%。住院时间缩短40%,伤口面积缩小率高18%,表明愈合过程更有效。此外,值得注意的是观察组问题发生率较低,这突出了该软膏在促进伤口愈合和减轻术后困难方面的有效性。
已发现将复方多粘菌素B软膏用作肛周脓肿手术治疗的辅助措施,对伤口愈合、缓解疼痛和减少并发症有重大积极影响。这一发现为该软膏在这一特定患者群体的术后伤口护理程序中作为有益补充的可能性提供了证据。